ZLAB Q3 2021 Earnings — Zai Lab Limited Revenue & Financial Results | Market Cap Arena

ZLABZai Lab Limited

$2B

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$43M+194.2% YoY

Gross Profit

-$24M-56.2% margin

Operating Income

-$83M-193.0% margin

Net Income

-$96M-223.7% margin

EPS (Diluted)

$-10.10

QoQ Revenue Growth

+16.7%

Cash Flow

Operating Cash Flow

-$161M

Free Cash Flow

-$167M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$140M

Stockholders' Equity

$1.6B

Cash & Equivalents

$1.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$43M	$15M	+194.2%
Gross Profit	-$24M	$10M	-349.1%
Operating Income	-$83M	-$76M	-9.1%
Net Income	-$96M	-$64M	-51.3%

Revenue Segments

Zejula

$28M65%

Optune

$11M25%

Qinlock

$4M10%